149. Hemiconvulsion hemiplegia epilepsy syndrome Clinical trials / Disease details


Clinical trials : 25 Drugs : 40 - (DrugBank : 14) / Drug target genes : 17 - Drug target pathways : 20

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2011-004114-42-BE
(EUCTR)
06/04/2021Fenfluramine as anti-epilepticum in a difficult to treat epilepsy syndrome.Fenfluramine as anti-epilepticum in Dravet syndrome. Fenfluramine is an amphetamine which was in the past used as anorexigan. Their are a few publications of effectivness of this medication in epilepsy.We want to investigate was is the exact place of fenfluramine in the treatment of a therapy resitant epilepsy named Dravet syndrome.
MedDRA version: 21.0;Level: PT;Classification code 10015037;Term: Epilepsy;System Organ Class: 10029205 - Nervous system disorders;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
Product Name: fenfluramine
INN or Proposed INN: FENFLURAMINE
University Hospital AntwerpNULLNAFemale: yes
Male: yes
50Phase 3Belgium